German Health Review
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Germany

German Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.

Press releases published on April 29, 2025

InVitria Launches OptiLeukin 2: A Chemically Defined Recombinant IL-2 for Cell Therapy

InVitria Launches OptiLeukin 2: A Chemically Defined Recombinant IL-2 for Cell Therapy

Animal- and bacteria-free recombinant IL-2 enables safer, scalable immune cell expansion for CAR-T, NK, and iPSC-derived cell therapy workflows. JUNCTION CITY, KS, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- InVitria Launches OptiLeukin™ 2: A …

InVitria Unveils Optibumin 25: First Recombinant 25% Human Serum Albumin for Closed-System Biomanufacturing

InVitria Unveils Optibumin 25: First Recombinant 25% Human Serum Albumin for Closed-System Biomanufacturing

Recombinant alternative to plasma-derived HSA enables safer, scalable, closed-system cell …

Qruise expands into magnetic resonance with new simulation and control software, Resonance

Qruise expands into magnetic resonance with new simulation and control software, Resonance

Struggling to develop high-fidelity magnetic resonance pulse sequences? Introducing 𝗥𝗲𝘀𝗼𝗻𝗮𝗻𝗰𝗲, the best solution for designing robust, selective pulses SAARBRüCKEN, SAARLAND, GERMANY, April 29, 2025 /⁨EINPresswire.com⁩/ -- Today, Qruise announced the …

Milwaukee Rehabilitation Hospital Announces New Chief Executive Officer

Milwaukee Rehabilitation Hospital Announces New Chief Executive Officer

Bruce Eady, Experienced CEO, Takes the Helm at Milwaukee Rehab Hospital at Greenfield MILWAUKEE, WI, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- Bruce Eady brings over three decades of healthcare experience, with two decades as an executive …

EVONOMY Group & SC Automotive Engineering expand offerings with services partnership

EVONOMY Group & SC Automotive Engineering expand offerings with services partnership

Combined services will deliver architecture, design engineering, embedded development, project management, and test services to OEMs in multiple industries DETROIT, MI, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- EVONOMY Group, a leader in E/E …

From Vietnam to Central Asia: GESO SYSTEMS Accelerates Its Globalization Strategy Once Again

From Vietnam to Central Asia: GESO SYSTEMS Accelerates Its Globalization Strategy Once Again

SHANGHAI, CHINA, April 29, 2025 /⁨EINPresswire.com⁩/ -- On April 22, 2025, the British GESO SYSTEMS was invited to participate in the Air Compressor Industry Product Exchange Meeting in Almaty, Kazakhstan, and discussed cooperation with industry …

The Dealmakers Announces 'Investors Roundtable in Malta' in Strategic Cooperation with FinanceMalta

The Dealmakers Announces 'Investors Roundtable in Malta' in Strategic Cooperation with FinanceMalta

Connecting global investors with Malta’s key industries to foster cross-border partnerships, innovation, and strategic growth through FinanceMalta's support. DUBAI, UNITED ARAB EMIRATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- The Dealmakers, the …

Substance use accelerates brain aging through distinct molecular pathways, groundbreaking study reveals

Substance use accelerates brain aging through distinct molecular pathways, groundbreaking study reveals

New research from UTHealth Houston reveals that substance use disorders accelerate biological aging in the brain through substance-specific molecular pathways. HOUSTON, TX, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- In a comprehensive Genomic …

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications

MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billion[1] Henlius to develop and manufacture biosimilar, with Sandoz to …

Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting

Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting

An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective response rate (33.3% vs 5.6%) and longer …

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Ingelheim, Germany, Oxford and Belfast, UK, April 29, 2025 – Boehringer Ingelheim, the University of Oxford, and Cumulus Neuroscience are joining forces to provide insights into the day-to-day experiences of people living with psychiatric disorders, and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service